US Patent 11111285 Glucagon-GLP-1-GIP triple agonist compounds
Patent 11111285 was granted and assigned to Zealand Pharma A/S on September, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 4, 2018
Date of Patent
September 7, 2021
Patent Applicant
Patent Application Number
20181004
Patent Jurisdiction
Patent Number
Find more entities like US Patent 11111285 Glucagon-GLP-1-GIP triple agonist compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
